Performing Two 6MWTs in Pulmonary Hypertension Minimizes "Learning Effect"
More than half of participants in the initial assessment were able to walk farther in the second 6MWT vs the first.
The 6-minute walk test had prognostic value with respect to mortality in a population of patients with pulmonary arterial hypertension.
Individuals treated with riociguat for pulmonary hypertension may have a greater risk for gastrointestinal disorders compared with tadalafil and sildenafil.
Brain natriuretic peptide levels may accurately predict 5-year survival rates in patients with pulmonary arterial hypertension.